Literature DB >> 22351761

Crystal structure of N-glycosylated human glypican-1 core protein: structure of two loops evolutionarily conserved in vertebrate glypican-1.

Gabriel Svensson1, Wael Awad, Maria Håkansson, Katrin Mani, Derek T Logan.   

Abstract

Glypicans are a family of cell-surface proteoglycans that regulate Wnt, hedgehog, bone morphogenetic protein, and fibroblast growth factor signaling. Loss-of-function mutations in glypican core proteins and in glycosaminoglycan-synthesizing enzymes have revealed that glypican core proteins and their glycosaminoglycan chains are important in shaping animal development. Glypican core proteins consist of a stable α-helical domain containing 14 conserved Cys residues followed by a glycosaminoglycan attachment domain that becomes exclusively substituted with heparan sulfate (HS) and presumably adopts a random coil conformation. Removal of the α-helical domain results in almost exclusive addition of the glycosaminoglycan chondroitin sulfate, suggesting that factors in the α-helical domain promote assembly of HS. Glypican-1 is involved in brain development and is one of six members of the vertebrate family of glypicans. We expressed and crystallized N-glycosylated human glypican-1 lacking HS and N-glycosylated glypican-1 lacking the HS attachment domain. The crystal structure of glypican-1 was solved using crystals of selenomethionine-labeled glypican-1 core protein lacking the HS domain. No additional electron density was observed for crystals of glypican-1 containing the HS attachment domain, and CD spectra of the two protein species were highly similar. The crystal structure of N-glycosylated human glypican-1 core protein at 2.5 Å, the first crystal structure of a vertebrate glypican, reveals the complete disulfide bond arrangement of the conserved Cys residues, and it also extends the structural knowledge of glypicans for one α-helix and two long loops. Importantly, the loops are evolutionarily conserved in vertebrate glypican-1, and one of them is involved in glycosaminoglycan class determination.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22351761      PMCID: PMC3340175          DOI: 10.1074/jbc.M111.322487

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  53 in total

Review 1.  Error estimation and bias correction in phase-improvement calculations.

Authors:  K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1999-09

2.  Molecular cloning and expression of human chondroitin N-acetylgalactosaminyltransferase: the key enzyme for chain initiation and elongation of chondroitin/dermatan sulfate on the protein linkage region tetrasaccharide shared by heparin/heparan sulfate.

Authors:  Toru Uyama; Hiroshi Kitagawa; Jun-ichi Tamura Ji; Kazuyuki Sugahara
Journal:  J Biol Chem       Date:  2002-01-11       Impact factor: 5.157

3.  Breaking good resolutions with ARP/wARP.

Authors:  Richard J Morris; Petrus H Zwart; Serge Cohen; Francisco J Fernandez; Mattheos Kakaris; Olga Kirillova; Clemens Vonrhein; Anastassis Perrakis; Victor S Lamzin
Journal:  J Synchrotron Radiat       Date:  2003-11-28       Impact factor: 2.616

4.  Substructure solution with SHELXD.

Authors:  Thomas R Schneider; George M Sheldrick
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2002-09-28

5.  Mechanisms underlying preferential assembly of heparan sulfate on glypican-1.

Authors:  R L Chen; A D Lander
Journal:  J Biol Chem       Date:  2000-12-05       Impact factor: 5.157

6.  Mutational analysis of the GPC3/GPC4 glypican gene cluster on Xq26 in patients with Simpson-Golabi-Behmel syndrome: identification of loss-of-function mutations in the GPC3 gene.

Authors:  M Veugelers; B D Cat; S Y Muyldermans; G Reekmans; N Delande; S Frints; E Legius; J P Fryns; C Schrander-Stumpel; B Weidle; N Magdalena; G David
Journal:  Hum Mol Genet       Date:  2000-05-22       Impact factor: 6.150

7.  Role of glypican 4 in the regulation of convergent extension movements during gastrulation in Xenopus laevis.

Authors:  Bisei Ohkawara; Takamasa S Yamamoto; Masazumi Tada; Naoto Ueno
Journal:  Development       Date:  2003-05       Impact factor: 6.868

8.  The tumor suppressor EXT-like gene EXTL2 encodes an alpha1, 4-N-acetylhexosaminyltransferase that transfers N-acetylgalactosamine and N-acetylglucosamine to the common glycosaminoglycan-protein linkage region. The key enzyme for the chain initiation of heparan sulfate.

Authors:  H Kitagawa; H Shimakawa; K Sugahara
Journal:  J Biol Chem       Date:  1999-05-14       Impact factor: 5.157

9.  Maximum-likelihood density modification.

Authors:  T C Terwilliger
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2000-08

10.  Processing by proprotein convertases is required for glypican-3 modulation of cell survival, Wnt signaling, and gastrulation movements.

Authors:  Bart De Cat; Sin-Ya Muyldermans; Christien Coomans; Gisèle Degeest; Bernadette Vanderschueren; John Creemers; Frédéric Biemar; Bernard Peers; Guido David
Journal:  J Cell Biol       Date:  2003-11-10       Impact factor: 10.539

View more
  26 in total

1.  Multiscale Simulations of Biological Membranes: The Challenge To Understand Biological Phenomena in a Living Substance.

Authors:  Giray Enkavi; Matti Javanainen; Waldemar Kulig; Tomasz Róg; Ilpo Vattulainen
Journal:  Chem Rev       Date:  2019-03-12       Impact factor: 60.622

Review 2.  Insights into the key roles of proteoglycans in breast cancer biology and translational medicine.

Authors:  Achilleas D Theocharis; Spyros S Skandalis; Thomas Neill; Hinke A B Multhaupt; Mario Hubo; Helena Frey; Sandeep Gopal; Angélica Gomes; Nikos Afratis; Hooi Ching Lim; John R Couchman; Jorge Filmus; Ralph D Sanderson; Liliana Schaefer; Renato V Iozzo; Nikos K Karamanos
Journal:  Biochim Biophys Acta       Date:  2015-03-28

Review 3.  Role of Matricellular Proteins in Disorders of the Central Nervous System.

Authors:  A R Jayakumar; A Apeksha; M D Norenberg
Journal:  Neurochem Res       Date:  2016-11-23       Impact factor: 3.996

4.  Xylose phosphorylation functions as a molecular switch to regulate proteoglycan biosynthesis.

Authors:  Jianzhong Wen; Junyu Xiao; Meghdad Rahdar; Biswa P Choudhury; Jixin Cui; Gregory S Taylor; Jeffrey D Esko; Jack E Dixon
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-20       Impact factor: 11.205

5.  Structural Aspects of N-Glycosylations and the C-terminal Region in Human Glypican-1.

Authors:  Wael Awad; Barbara Adamczyk; Jessica Örnros; Niclas G Karlsson; Katrin Mani; Derek T Logan
Journal:  J Biol Chem       Date:  2015-07-22       Impact factor: 5.157

Review 6.  Glypicans as Cancer Therapeutic Targets.

Authors:  Nan Li; Wei Gao; Yi-Fan Zhang; Mitchell Ho
Journal:  Trends Cancer       Date:  2018-09-28

7.  Therapeutically targeting glypican-3 via a conformation-specific single-domain antibody in hepatocellular carcinoma.

Authors:  Mingqian Feng; Wei Gao; Ruoqi Wang; Weizao Chen; Yan-Gao Man; William Douglas Figg; Xin Wei Wang; Dimiter S Dimitrov; Mitchell Ho
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-05       Impact factor: 11.205

8.  Two functional domains in C. elegans glypican LON-2 can independently inhibit BMP-like signaling.

Authors:  Suparna Taneja-Bageshwar; Tina L Gumienny
Journal:  Dev Biol       Date:  2012-08-18       Impact factor: 3.582

9.  Inactivation of Wnt signaling by a human antibody that recognizes the heparan sulfate chains of glypican-3 for liver cancer therapy.

Authors:  Wei Gao; Heungnam Kim; Mingqian Feng; Yen Phung; Charles P Xavier; Jeffrey S Rubin; Mitchell Ho
Journal:  Hepatology       Date:  2014-06-18       Impact factor: 17.425

Review 10.  Glypican-3 antibodies: a new therapeutic target for liver cancer.

Authors:  Mingqian Feng; Mitchell Ho
Journal:  FEBS Lett       Date:  2013-10-15       Impact factor: 4.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.